Dr Lal PathLabs Leads as India’s Diagnostics Sector Splits on Volume vs Margin in Q1 FY27
Dr Lal PathLabs posted 15% revenue growth and held EBITDA margins above 26% in Q1 FY27, reinforcing its position as the diagnostics sector's operational benchmark while Metropolis Healthcare sharpened its focus on

Follow